Evidence map›Paper›PMID 20668217›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation.

Amarjit S Naura, Mourad Zerfaoui, Hogyoung Kim, Zakaria Y Abd Elmageed, Paulo C Rodriguez, Chetan P Hans, Jihang Ju, Youssef Errami, Jiwon Park, Augusto C Ochoa and 1 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. MicroRNA-21 promotes epithelial-mesenchymal transition and migration of human bronchial epithelial cells by targeting poly (ADP-ribose) polymerase-1 and activating PI3K/AKT signaling.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2022
    Article
  10. Article
  11. CBClinical and translational medicine · 2021
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Amarjit S NauraDepartment of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA. anaura@lsuhsc.edu
Mourad Zerfaoui
Hogyoung Kim
Zakaria Y Abd Elmageed
Paulo C Rodriguez
Chetan P Hans
Jihang Ju
Youssef Errami
Jiwon Park
Augusto C Ochoa
A Hamid Boulares
Louisiana State University Health Sciences Center New Orleans · USStanley Foundation · US

Funding

TUMOR MICROENVIRONMENT AND B CELL LYMPHOMASP20RR021970 · NCRR · LSU HEALTH SCIENCES CENTER · PI THOMPSON, HILARY W · 2005 to 2011
$14.1M
Mentoring Translational Researchers in LouisianaP20GM103501 · NIGMS · LSU HEALTH SCIENCES CENTER · PI OCHOA, AUGUSTO C. · 2012 to 2014
$6.3M
Arginase Production in Cancer: Evading Immune ResponseR01CA107974 · NCI · LSU HEALTH SCIENCES CENTER · PI OCHOA, AUGUSTO C. · 2004 to 2015
$3.6M
PARTICIPATION OF PARP-1 IN THE PATHOGENESIS OF ASTHMAR01HL072889 · NHLBI · LSU HEALTH SCIENCES CENTER · PI BOULARES, HAMID · 2004 to 2015
$3.4M
INDUCTION OF ANERGY AND ALTERED SIGNAL TRANSDUCTIONR01CA082689 · NCI · LSU HEALTH SCIENCES CENTER · PI OCHOA, AUGUSTO C. · 1999 to 2013
$3.1M
NCI NIH HHS R01 CA082689NCI NIH HHS R01 CA107974NCRR NIH HHS P20 RR021970NHLBI NIH HHS HL072889NHLBI NIH HHS R01 HL072889NIGMS NIH HHS P20 GM103501
6 · The paper itself

Abstract

The role of inducible NO synthase (iNOS) in allergic airway inflammation remains elusive. We tested the hypothesis that iNOS plays different roles during acute versus chronic airway inflammation. Acute and chronic mouse models of OVA-induced airway inflammation were used to conduct the study. We showed that iNOS deletion was associated with a reduction in eosinophilia, mucus hypersecretion, and IL-5 and IL-13 production upon the acute protocol. Such protection was completely abolished upon the chronic protocol. Interestingly, pulmonary fibrosis observed in wild-type mice under the chronic protocol was completely absent in iNOS(-/-) mice despite persistent IL-5 and IL-13 production, suggesting that these cytokines were insufficient for pulmonary fibrosis. Such protection was associated with reduced collagen synthesis and indirect but severe TGF-beta modulation as confirmed using primary lung smooth muscle cells. Although activation of matrix metalloproteinase-2/-9 exhibited little change, the large tissue inhibitor of metalloproteinase-2 (TIMP-2) increase detected in wild-type mice was absent in the iNOS(-/-) counterparts. The regulatory effect of iNOS on TIMP-2 may be mediated by peroxynitrite, as the latter reversed TIMP-2 expression in iNOS(-/-) lung smooth muscle cells and fibroblasts, suggesting that the iNOS-TIMP-2 link may explain the protective effect of iNOS-knockout against pulmonary fibrosis. Analysis of lung sections from chronically OVA-exposed iNOS(-/-) mice revealed evidence of residual but significant protein nitration, prevalent oxidative DNA damage, and poly(ADP-ribose) polymerase-1 activation. Such tissue damage, inflammatory cell recruitment, and mucus hypersecretion may be associated with substantial arginase expression and activity. The results in this study exemplify the complexity of the role of iNOS in asthma and the preservation of its potential as a therapeutic a target.

Indexed as

Acute DiseaseAllergensAnimalsCells, CulturedChickensEosinophiliaGene DeletionInflammationInflammation MediatorsInterleukin-13MiceMice, Inbred C57BLMice, KnockoutMucusNitric Oxide Synthase Type IIOvalbuminAllergensInflammation MediatorsInterleukin-13Nitric Oxide Synthase Type IINos2 protein, mouseOvalbumin

Identifiers

PMID20668217
PMCPMC3077076
OpenAlexW2146030797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.